Aquilo Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,403,210
| Closed | -$6.81M | – | 14 |
|
|
2022
Q3 | $6.81M | Sell |
3,403,210
-1,918,021
| -36% | -$3.84M | 2.45% | 12 |
|
|
2022
Q2 | $3.94M | Buy |
5,321,231
+39,727
| +0.8% | +$29.4K | 1.35% | 12 |
|
|
2022
Q1 | $45.9M | Buy |
5,281,504
+317,323
| +6% | +$2.76M | 6.75% | 4 |
|
|
2021
Q4 | $79.5M | Buy |
4,964,181
+400,493
| +9% | +$6.41M | 9.01% | 1 |
|
|
2021
Q3 | $84M | Buy |
4,563,688
+734,479
| +19% | +$13.5M | 15.26% | 1 |
|
|
2021
Q2 | $53.5M | Hold |
3,829,209
| – | – | 13.89% | 2 |
|
|
2021
Q1 | $56.4M | Sell |
3,829,209
-103,000
| -3% | -$1.52M | 10.19% | 1 |
|
|
2020
Q4 | $76.2M | Sell |
3,932,209
-564,933
| -13% | -$11M | 15.85% | 1 |
|
|
2020
Q3 | $50.2M | Buy |
4,497,142
+2,554,061
| +131% | +$28.5M | 5.31% | 1 |
|
|
2020
Q2 | $26.3M | Buy |
1,943,081
+124,941
| +7% | +$1.69M | 5.3% | 4 |
|
|
2020
Q1 | $14.7M | Buy |
1,818,140
+663,784
| +58% | +$5.36M | 5.73% | 5 |
|
|
2019
Q4 | $11.1M | Hold |
1,154,356
| – | – | 4.17% | 8 |
|
|
2019
Q3 | $12.2M | Hold |
1,154,356
| – | – | 8.62% | 3 |
|
|
2019
Q2 | $13.3M | Buy |
1,154,356
+100,000
| +9% | +$1.15M | 4.61% | 4 |
|
|
2019
Q1 | $13.5M | Buy |
1,054,356
+22,409
| +2% | +$287K | 5.98% | 4 |
|
|
2018
Q4 | $6.35M | Buy |
1,031,947
+232,256
| +29% | +$1.43M | 3.07% | 7 |
|
|
2018
Q3 | $8.41M | Buy |
799,691
+383,000
| +92% | +$4.03M | 3.52% | 8 |
|
|
2018
Q2 | $6.11M | Buy |
+416,691
| New | +$6.11M | 5.04% | 7 |
|